Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct-Dec;69(4):243-244.
doi: 10.4103/jpgm.jpgm_326_23.

How early is too early? Diagnosis of tuberous sclerosis complex in a neonate

Affiliations

How early is too early? Diagnosis of tuberous sclerosis complex in a neonate

R R Prashanth et al. J Postgrad Med. 2023 Oct-Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
(a) ash leaf macules with well-defined margins (black arrows); (b) ash leaf macule under Wood’s lamp examination (black arrow)
Figure 2
Figure 2
(a) funduscopy showing retinal astrocytoma (black arrow); (b) ultrasound abdomen showing renal cortical cyst (black arrow); (c) 2DECHO showing rhabdomyoma in the left ventricle (black arrow); (d) MRI brain showing cortical tubers (black arrows)

References

    1. Cardis MA, DeKlotz CMC. Cutaneous manifestations of tuberous sclerosis complex and the paediatrician's role. Arch Dis Child. 2017;102:858–63. - PMC - PubMed
    1. Northrup H, Krueger DA. International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49:243–54. - PMC - PubMed
    1. Jung TY, Kim YH, Jung S, Baek HJ, Lee KH. The clinical characteristics of subependymal giant cell astrocytoma: Five cases. Brain Tumor Res Treat. 2015;3:44–7. - PMC - PubMed
    1. Kotulska K, Kwiatkowski DJ, Curatolo P, Weschke B, Riney K, Jansen F, et al. Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP trial. Ann Neurol. 2021;89:304–14. - PMC - PubMed
    1. French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): A phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016;388:2153–63. - PubMed